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‘You must be the change you wish to see in the world.’
(Mahatma Gandhi)
The ‘European Antibiotic Awareness Day’ will take place on
18 November, and is now a well-known event, 6 years after its
ﬁrst launch by the European Centre for Disease Prevention and
Control [1]. Bacterial resistance is increasing worldwide; it has
been identiﬁed as one of the most serious public health issues of
our time by theWHO, andwas qualiﬁed as a ‘problem so serious
that it threatens the achievements of modern medicine. A
post-antibiotic era—in which common infections and minor
injuries can kill—far from being an apocalyptic fantasy, is instead
a very real possibility for the 21st century’ [2]. If we are not to
face such a frightening situation, international awareness of the
issue is urgently needed, followed by strong and courageous
global and coordinated actions [3].
Scientists, including infectious diseases specialists and clinical
microbiologists, have been trying to raise awareness for more
than a decade. The ESCMID has been particularly active, and
created the ESCMID Study Group for Antibiotic Policies
(https://www.escmid.org/research_projects/study_groups/anti-
biotic_policies/) [4]. In this issue, Carlet et al. [5] demonstrate
why bacterial resistance is now a geopolitical issue, and
present suggestions to tackle this global threat. If national and
local activities are important, the involvement and commit-
ment of national and international policy-makers and politi-
cians are necessary if solutions are to have a chance to be
effective.
Politicians are concerned by public health issues, but also by
the economic impact of bacterial resistance. In this issue,
Gandra et al. [6] provide evidence of the disastrous inﬂuence
of bacterial resistance on economics. The authors underline
several factors that are often overlooked in studies assessing
the economic impact of bacterial resistance: the increasing
prevalence of resistant bacteria, the cost of infections caused
by these resistant bacteria, and the deleterious effect of
bacterial resistance outside of the hospital or the healthcare
setting.
Three main areas need to be targeted in order to try to curb
bacterial resistance, both in human and veterinary medicine:
antimicrobial stewardship, hygiene and vaccination, and mea-
sures to reduce the risk of bacterial spread in the environment.
Antimicrobial stewardship programmes have proved their
usefulness worldwide, but are not implemented everywhere,
mostly because of lack of leadership and resources. In this issue,
Huttner et al. [7] highlight some of the success stories of
antimicrobial stewardship programmes, and describe the
actions that have been taken, the outcomes that have been
obtained, and the obstacles that have been met. They clearly
demonstrate that antimicrobial stewardship programmes can
and should be implemented worldwide, in all settings (primary
care, long-term-care facilities, and hospitals).
Infectious diseases specialists, clinical microbiologists and
clinical pharmacists must work together and constitute the core
of the antimicrobial stewardship programmes. The value of
infectious diseases specialists has been disputed for years, but
has been increasingly acknowledged. Finally, in this issue, Pulcini
et al. [8] provide strong evidence demonstrating the positive
impact of infectious diseases specialists on antibiotic prescribing
in hospitals. In this narrative review, intervention by infectious
diseases specialists was associated with a signiﬁcant improve-
ment in the appropriateness of antibiotic prescribing, and with
decreased antibiotic use in almost all included studies. Several
studies also showed that intervention by infectious diseases
specialists was associated with reduced length of stay,
decreased mortality, a reduction in the prevalence of multire-
sistant bacteria, and a reduction in the costs of antibiotics.
In conclusion, bacterial resistance is an international emer-
gency, and implementing antimicrobial stewardship pro-
grammes is a necessity; the scientiﬁc evidence is there, and
the time for action is now.
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